Clinical Trial Update: Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating cabergoline versus a GnRH antagonist rescue and cabergoline for the prevention of ovarian hyperstimulation sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• CABERGOLINE (CABERGOLINE)
• GnRH antagonist

Snippet

Sponsor: Aljazeera Hospital | Conditions: OHSS | Phase 2 | Status: UNKNOWN